Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pol Merkur Lekarski ; 13 Suppl 1: 33-6, 2002 Nov.
Artigo em Polonês | MEDLINE | ID: mdl-12621779

RESUMO

The vascular hallmark of chronic rejection (CR), as well as of atherosclerosis, is initial hyperplasia. It results from migration and proliferation of vascular smooth muscle cell and increased deposition of extracellular matrix proteins. A possible mechanism responsible for formation of neointima is the release of growth factors and cytokines, such as: transforming growth factor beta (TGF-beta), tumour necrosis factor alfa (TNF-alpha), interleukin 1 (IL-1) and interleukin 6 (IL-6). The expression of these factors in the renal artery wall of chronically rejected allografts was quantified. The renal artery samples were obtained from patients with chronic renal allograft rejection, undergoing graftectomy (n = 11) and patients with autosomal dominant polycystic kidney disease (ADPKD), undergoing nephrectomy (n = 4). Total RNA was isolated and the expression of mRNA for TGF-beta, TNF-alpha, IL-1 and IL-6 was measured using a real time PCR. In patients with CR the expression levels of TGF-beta, TNF-alpha and IL-1 mRNA were higher than in control group. No difference between groups was detected for IL-6. In both groups a correlation was detected between age and TGF-beta expression. The increased expression of TGF-beta, TNF-alpha and IL-1 may be a key factor in the neointimal formation and pathogenesis of CR. The increase in the TGF-b expression with age might be a protective mechanism in atherosclerosis.


Assuntos
Citocinas/metabolismo , Rejeição de Enxerto/imunologia , Substâncias de Crescimento/metabolismo , Transplante de Rim/efeitos adversos , Rim Policístico Autossômico Dominante/imunologia , RNA Mensageiro/metabolismo , Adulto , Idoso , Estudos de Casos e Controles , Citocinas/genética , Feminino , Expressão Gênica , Rejeição de Enxerto/patologia , Substâncias de Crescimento/genética , Humanos , Hiperplasia , Interleucina-1/metabolismo , Interleucina-6/metabolismo , Transplante de Rim/imunologia , Transplante de Rim/patologia , Masculino , Pessoa de Meia-Idade , Rim Policístico Autossômico Dominante/patologia , Reação em Cadeia da Polimerase , Artéria Renal/fisiopatologia , Fator de Crescimento Transformador beta/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...